New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...

TAU’s vice president for research and development said that they worked on the project for two-and-a-half years and were very ...

A safe and effective pneumonic plague vaccine would thwart the use of Y. pestis as an agent of ... Current Challenges in the Development of Vaccines for Pneumonic Plague - Medscape - Mar 01, 2008.

Anderson et al. Pneumonic Plague Pathogenesis and Immunity in Brown Norway Rats. American Journal Of Pathology , 2009; 174 (3): 910 DOI: 10.2353/ajpath.2009.071168 Cite This Page : ...

Scientists in Tel Aviv and IIBR have developed an mRNA vaccine. It combats the deadly Yersinia pestis bacterium. This bacterium causes plague. The vaccine showed 100% effectiveness in animal trials.

Most people don’t need to be concerned about the plague based on a recent death in Arizona. But take precautions if you live ...

A Coconino County resident died of a rare case of pneumonic plague earlier this month. Dave Wagner, director of Northern ...

Pneumonic plague is both “the least common and most dangerous type of plague,” according to the Cleveland Clinic.

The patient had the pneumonic plague, the rarest and deadliest form of the disease. Human cases remain very uncommon in the ...

Pneumonic plague, caused by the ... host immune responses and the development of both diagnostic and prophylactic tools. ... Studies have highlighted sex-based differences in vaccine efficacy, ...

A person has died of the pneumonic plague at the Flagstaff Medical Center in Arizona, according to Northern Arizona ...

The history and status of plague vaccine research is discussed. Learn why pneumonic plague vaccines should strive to prime both humoral and cellular immunity.